Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Healthcare Biotechnology
Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Noxopharm Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Comment by GoldMan22on Jun 01, 2010 10:37am
243 Views
Post# 17146270

RE: RE: RE: RE: RE: RE: If I had a million dollars

RE: RE: RE: RE: RE: RE: If I had a million dollars...not my point..how does stock move with no PR!

I know something is up, but what triggering all these trades??? Not fair for regular traders like you and me!

It's up .035 and 482300 shares traded!

Recent Trades - Last 10 of 35
Time ET Ex Price Change Volume Buyer Seller Markers
10:20:37 V 0.275 0.035 10,000 85 Scotia 7 TD Sec K
10:18:48 V 0.27 0.03 6,000 85 Scotia 26 Commission Direct K
10:18:05 V 0.27 0.03 19,000 7 TD Sec 26 Commission Direct KW
10:17:48 V 0.27 0.03 5,000 7 TD Sec 2 RBC K
10:17:37 V 0.27 0.03 1,000 7 TD Sec 26 Commission Direct K
10:16:58 V 0.27 0.03 3,000 99 Jitney 26 Commission Direct K
10:16:49 V 0.27 0.03 21,000 59 PI 26 Commission Direct K
10:16:49 V 0.27 0.03 4,000 59 PI 7 TD Sec K
10:13:40 V 0.27 0.03 1,000 2 RBC 7 TD Sec K
10:13:40 V 0.27 0.03 15,000 2 RBC 7 TD Sec K




Bullboard Posts
Dealroom for high-potential pre-IPO opportunities